A14UQC
Abivax SA · LSX:A14UQC
77.70 EUR−2.85 −3.54%
Abivax SA (LSX:A14UQC) last traded at 77.70 EUR, down 3.54% on the day. Over the past year the stock is down 14.43%. Its 52-week range is 60.40 to 153.00. It is in the Health Technology sector (Pharmaceuticals: Other).
Key statistics
Open77.90
Day range77.70 – 77.90
52-week range60.40 – 153.00
Volume81
Average volume (10 days)54
Market cap (USD)7.45 B
EPS (TTM) (USD)−5.98
Dividend yield0.00%
Beta (1 year)1.66
Revenue (TTM) (USD)0
Employees69
Performance
−4.66%1 week
−7.39%1 month
−28.32%3 months
−27.04%6 months
−34.26%Year to date
−14.43%1 year
Technical reading
Strongly bearish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Abivax to Participate in Upcoming Fall Investor ConferencesEQS · 02 Nov 2026
- Abivax to Participate in Upcoming Fall Investor ConferencesGlobeNewswire · 02 Nov 2026
- Abivax Price Target Cut to $96.00/Share From $118.00 by WedbushDow Jones Newswires · 21 Oct 2026
- Abivax Price Target Maintained With a $175.00/Share by GuggenheimDow Jones Newswires · 20 Oct 2026
- Cedar Grove Capital Q3: Adds Zedcor, Auxly; exits MTY, ClearPointSeeking Alpha · 15 Oct 2026
- Seeking Alpha’s Quant Spotlight: Highest and lowest rated healthcare stocks ahead of Q3Seeking Alpha · 13 Oct 2026
- Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026EQS · 30 Sep 2026
- Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026GlobeNewswire · 30 Sep 2026
Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.